The Inspirational Quest to Eradicate Cancer

The world-renowned Thoracic Oncologist, Dr. Gerold Bepler, joined I Don’t Care’s Kevin Stevenson for a conversation that was no less than inspirational. Dr. Bepler, President and CEO of the Karmanos Cancer Institute, has a mission; to eradicate cancer. It’s more than a dream for Dr. Bepler; he believes it will be a reality one day.

Dr. Bepler arrived from Germany to the United States in 1983. Following a post-doctoral fellowship at the National Cancer Institute, the starting point for his journey into lung cancer research. This career path took Dr. Bepler through many stops along the way, and in 2010 he joined the Karmanos Cancer Institute.

The mission to eradicate cancer got a boost in 1971 with the National Cancer Act, and Dr. Bepler said there’s tremendous progress towards this goal since that point. “People now diagnosed with cancer have hope,” Dr. Bepler said. “And many of them get cured of the disease and have a good quality of life. That all wouldn’t have been possible without the National Cancer Act.”

Much of the progress made to eradicating cancer at the Karmanos Cancer Institute owes a debt of gratitude to that 50-year-old law for providing necessary funding that makes such research possible.

“The Karmanos Cancer Institute became one of the NCI designated cancer centers,” Dr. Bepler said. “Very quickly, the National Cancer Institute realized just having one cancer institute in Bethesda, Maryland alone wouldn’t be able to achieve that high goal of eradicating cancer. This network established cancer centers throughout the United States.” What started as a couple of centers in the 1970s is now more than 50 comprehensive cancer centers.

The world now possesses many drugs and treatments to treat cancer through the dedication and research of institutes like the Karmanos Center. And some research led to treatments for other diseases. Dr. Bepler mentioned the Karmanos Center developed three of the first FDA-approved AIDS drugs.

More Like This Story:

The Rising Tide of Food Allergens

From an Idea to Billion Dollar Company: How a Doctor Lobbied DC for HSAs

Follow us on social media for the latest updates in B2B!

Image

Latest

automation
Revolutionizing Revenue Cycle Management: The Power of AI & Automation
July 7, 2025

Amid a rapidly evolving tech landscape, decision-makers need to navigate new AI-driven solutions addressing industry-specific hurdles. This session, recorded at the HFMA 2025 show, sheds light on how leaders are using pioneering automation technologies to stay competitive and efficient.

Read More
Portable AV system
AV Anywhere: Portable AV Systems Are Now Essential for Mission-Critical Response in Unpredictable, Connectivity-Challenged Environments
July 7, 2025

In crisis scenarios, portable AV systems must perform under pressure because failure is not an option. As Keysight Technologies notes, the evolution of mission-critical communications now depends on low-latency, mobile-ready platforms that can operate reliably in unstable, infrastructure-poor conditions, making portable AV systems essential for real-time response and public safety operations. These are the…

Read More
future of marketing
Vibes and the Future of Marketing with Adbloom Founder and CEO Andrew Abony
July 7, 2025

Affiliate marketing is shedding its outdated reputation and entering a new era—one centered on authenticity, emotional resonance, and genuine human connection. As the future of marketing becomes increasingly relationship-driven, this shift is impossible to ignore. In fact, during the 2024 U.S. Cyber Monday, influencers and affiliate marketers were responsible for driving around 20% of…

Read More
brand identity
The Branding Balancing Act: Reinvent Without Losing Your Brand Identity
July 7, 2025

The recent resurrection of the Pac-12—reborn with new members and a possible rebrand—raises critical questions about what keeps a brand relevant in the face of disruption. According to Yahoo Sports, the rebuilt conference has signed a five-year media deal with CBS despite fielding just two original members, underscoring how legacy names must evolve to maintain…

Read More